Table 1

General characteristics of the cohort

Overall cohortN=81 363
Age (years) (±SD)65 (11)
Sex, female (%)74 772 (91.9)
Menopause, n (% of female)71 654 (95.8)
Weight (±SD)62.2 (12.0)
Height (±SD)160 (8)
Concomitant treatment (%)None69 616 (85.6)
Treatment with adjuvant hormone therapy6264 (7.7)
Glucocorticoids ≥5 mg/day of prednisone equivalent for ≥3 months5483 (6.7)
Diseases (%)None63 497 (78.0)
Rheumatoid arthritis3817 (4.7)
Psoriatic arthritis992 (1.2)
Systemic lupus erythematosus384 (0.5)
Systemic sclerosis374 (0.5)
Other connective tissue diseases2571 (3.2)
Inflammatory bowel diseases1250 (1.5)
Multiple sclerosis335 (0.4)
Diabetes4184 (5.1)
Chronic pulmonary diseases2097 (2.6)
Severe physical handicap1058 (1.3)
Parkinson’s disease502 (0.6)
HIV infection302 (0.4)
Specialty of the physician entering patients’ data (%)Rheumatology17 310 (21.3)
Endocrinology26 278 (32.3)
Family care practitioner10 207 (12.5)
Internal medicine5757 (7.1)
Orthopedy5699 (7.0)
Physiatry5420 (6.7)
Gynaecologist2328 (2.9)
Other8364 (10.3)